<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02218216</url>
  </required_header>
  <id_info>
    <org_study_id>114-2014-GES-0046</org_study_id>
    <nct_id>NCT02218216</nct_id>
  </id_info>
  <brief_title>TBI MR Study 3 Houston Methodist</brief_title>
  <official_title>Advanced MRI Applications for Mild Traumatic Brain Injury - Study 3</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GE Healthcare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This hypothesis-generating feasibility study to determine potential associations between a&#xD;
      broad range of clinical neurological symptoms and Magnetic Resonance Image (MRI), data, and&#xD;
      clinical findings involved in mild traumatic brain injury (mTBI). These associations will be&#xD;
      examined over the acute and sub-acute period (baseline to 3 months) following injury to&#xD;
      provide information useful for optimization of MR pulse sequences for mTBI applications.&#xD;
&#xD;
      The intent of this study is to broadly generate a range of potential mTBI biomarkers&#xD;
      detectable using investigational MR pulse sequence technologies. Feasibility data attained in&#xD;
      this study may be used for engineering program decision-making and in support of future&#xD;
      scientific assessment, engineering development, published research databases or registries&#xD;
      mTBI data and images, and other purposes determined by the Sponsor. The results of this study&#xD;
      are not intended for use in regulatory submissions.&#xD;
&#xD;
      Subjects will be examined on commercially available MR scanner using investigational or&#xD;
      standard of care MR coils and a series of investigational Application Packs containing a&#xD;
      predetermined set of MR pulse sequences optimized by Sponsor&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This hypothesis-generating feasibility study is being conducted to determine potential&#xD;
      associations between a broad range of clinical neurological symptoms and MR images, data, and&#xD;
      clinical findings involved in mild traumatic brain injury (mTBI). These associations will be&#xD;
      examined over the acute and sub-acute period (approximately 3 months) following injury to&#xD;
      provide information useful for optimization of MR pulse sequences for mTBI applications.&#xD;
&#xD;
      The intent of this study is to broadly generate a range of potential mTBI biomarkers&#xD;
      detectable using investigational MR pulse sequence technologies. Feasibility data attained in&#xD;
      this study may be used for engineering program decision-making and in support of future&#xD;
      scientific assessment, engineering development, published research databases or registries&#xD;
      mTBI data and images, and other purposes determined by the Sponsor. The results of this study&#xD;
      are not intended for use in regulatory submissions.&#xD;
&#xD;
      Subjects will be examined on commercially available MR scanners using investigational or&#xD;
      standard of care MR coils and a series of investigational Application Packs containing a&#xD;
      predetermined set of MR pulse sequences optimized by GEHC.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Sponsor terminated study early to start a larger feasability study&#xD;
  </why_stopped>
  <start_date>September 2014</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mTBI Progression Indicated by Clinical Neurological Characteristics, MRI Images, and Quantitative MRI Data From Novel Software</measure>
    <time_frame>Baseline to 3 months</time_frame>
    <description>To determine associations between clinical neurological data, MR images, quantitative data from novel software post-processing (sponsor developed software including Volumetry, Kurtosis, Resting State [RS], functional magnetic resonance imaging [fMRI], and additional post-processing modules may be provided</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <arm_group>
    <arm_group_label>Experimental: Diagnostic mTBI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MRI Diagnostic of subjects with mild Tramatic Brain Injury (mTBI)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental: Diagnostic Non mTBI</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>MRI Diagnostic of Non injured subjects that are closely matched to mTBI</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI Diagnostic</intervention_name>
    <description>Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences</description>
    <arm_group_label>Experimental: Diagnostic Non mTBI</arm_group_label>
    <arm_group_label>Experimental: Diagnostic mTBI</arm_group_label>
    <other_name>Magnetic Resonance Image</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Segment 1 (mTBI patient) Inclusion and Exclusion Criteria Inclusion Criteria for mTBI&#xD;
        subjects&#xD;
&#xD;
        Subjects included in the main part of this study (Segment 1) will:&#xD;
&#xD;
          1. Be aged ≥15 and ≤50 years old at the time of enrollment;&#xD;
&#xD;
          2. Be diagnosed with mTBI according to the standard diagnostic procedures at the&#xD;
             investigational site in a timeframe that meets enrollment criteria for enrollment in&#xD;
             one of the first two intervals of the study, as follows:&#xD;
&#xD;
               1. Meets criteria for enrollment in Encounter 1 (within 72 hours), or&#xD;
&#xD;
               2. Meets criteria for enrollment in Encounter 2 (within 8±2 days)&#xD;
&#xD;
          3. Be capable of sufficiently clear communication to allow the subject to provide written&#xD;
             informed consent, or assent with parental or guardian consent for minors as described&#xD;
             in Section 6.3 - Protection of Vulnerable Subjects, for participation in all parts of&#xD;
             the study.&#xD;
&#xD;
        Segment 1: Exclusion Criteria for mTBI subjects&#xD;
&#xD;
        Subjects will be excluded that have:&#xD;
&#xD;
          1. Loss of consciousness (LOC) ≥15 minutes;&#xD;
&#xD;
          2. Posttraumatic amnesia lasting ≥24 hr following a recent TBI event;&#xD;
&#xD;
          3. Diagnosis of moderate to severe TBI or GCS &lt;13;&#xD;
&#xD;
          4. Structural brain injury indicated by previous neuroimaging findings;&#xD;
&#xD;
          5. Previous history of moderate to severe TBI;&#xD;
&#xD;
          6. Any previous history of mild TBI within the past 12 months;&#xD;
&#xD;
          7. Previously diagnosed brain white matter disease;&#xD;
&#xD;
          8. History of seizures within the past 10 years;&#xD;
&#xD;
          9. History of self-reported illicit drug abuse (except marijuana) in past 10 years;&#xD;
&#xD;
         10. History of alcohol abuse or dependence (per DSM-IV-TR Diagnostic Criteria);&#xD;
&#xD;
         11. Current primary Axis I or II psychiatric disorders, except for disorders classified as&#xD;
             minor and not expected to impact study conduct or integrity (as detailed in Appendix F&#xD;
             - Screening for Exclusion based on Axis I or II Disorders):&#xD;
&#xD;
         12. History of brain mass;&#xD;
&#xD;
         13. History of neurosurgery;&#xD;
&#xD;
         14. History of stroke;&#xD;
&#xD;
         15. History of dementia;&#xD;
&#xD;
         16. Known cognitive dysfunction;&#xD;
&#xD;
         17. Known structural brain disease or malformation;&#xD;
&#xD;
         18. Current anti-psychotic or antiepileptic medication usage;&#xD;
&#xD;
         19. That are unable or unwilling to complete study procedures accurately or have any&#xD;
             conflict of interest that could affect study results, in the opinion of the&#xD;
             investigator;&#xD;
&#xD;
         20. Contraindications to MRI scanning, including:&#xD;
&#xD;
               1. Current or suspected pregnancy per site clinical practice;&#xD;
&#xD;
               2. Other conditions that may constitute a hazard to the subject during study&#xD;
                  participation, determined by the investigator;&#xD;
&#xD;
               3. Inability to comply with any part of the site's MR safety policy.&#xD;
&#xD;
        Segment 2 (non-TBI subject) Inclusion and Exclusion Criteria Inclusion Criteria for Non-TBI&#xD;
        subjects (Segment 2)&#xD;
&#xD;
        All included subjects will:&#xD;
&#xD;
          1. Aged ≥15 and ≤50 years old at the time of enrollment;&#xD;
&#xD;
          2. Be well matched to one or more mTBI patients in Segment 1, in the opinion of the&#xD;
             Principal Investigator, with regards to:&#xD;
&#xD;
               1. Age,&#xD;
&#xD;
               2. Gender,&#xD;
&#xD;
               3. Sociodemographic characteristics, and&#xD;
&#xD;
               4. Handedness.&#xD;
&#xD;
          3. Be capable of sufficiently clear communication to allow the subject to provide written&#xD;
             informed consent, or assent with parental or guardian consent for minors as described&#xD;
             in Section 6.3 - Protection of Vulnerable Subjects, for participation in all parts of&#xD;
             the study.&#xD;
&#xD;
        Exclusion Criteria for Non-TBI subjects (Segment 2)&#xD;
&#xD;
        Subjects will be excluded that:&#xD;
&#xD;
          1. Are currently pregnant based on subject self-report of pregnancy status;&#xD;
&#xD;
          2. Are currently enrolled in another Segment of this study;&#xD;
&#xD;
          3. Require medical care that would be adversely affected or delayed by participating, in&#xD;
             the opinion of a physician investigator;&#xD;
&#xD;
          4. Prior diagnosis of mild TBI within the past 12 months;&#xD;
&#xD;
          5. Have structural brain injury indicated by previous neuroimaging findings;&#xD;
&#xD;
          6. Previous history of moderate to severe TBI within the past 10 years;&#xD;
&#xD;
          7. Previously diagnosed brain white matter disease;&#xD;
&#xD;
          8. History of seizures within the past 10 years;&#xD;
&#xD;
          9. History of illicit drug abuse (except marijuana) within the past 10 years&#xD;
&#xD;
         10. History of alcohol abuse or dependence (per DSM-IV-TR Diagnostic Criteria);&#xD;
&#xD;
         11. Current primary Axis I or II psychiatric disorders, except for disorders classified as&#xD;
             minor and not expected to impact study conduct or integrity (as detailed in Appendix F&#xD;
             - Screening for Exclusion based on Axis I or II Disorders):&#xD;
&#xD;
         12. History of brain mass;&#xD;
&#xD;
         13. History of neurosurgery;&#xD;
&#xD;
         14. History of stroke;&#xD;
&#xD;
         15. History of dementia;&#xD;
&#xD;
         16. Known cognitive dysfunction;&#xD;
&#xD;
         17. Known structural brain disease or malformation;&#xD;
&#xD;
         18. Current anti-psychotic or antiepileptic medication usage;&#xD;
&#xD;
         19. Have contraindications to MRI scanning, including:&#xD;
&#xD;
               1. Current or suspected pregnancy per site clinical practice;&#xD;
&#xD;
               2. Other conditions that may constitute a hazard to the subject during study&#xD;
                  participation, determined by the investigator;&#xD;
&#xD;
               3. Inability to comply with any part of the site's MR safety policy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph C Masdeu, MD. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Houston Methodist Neurological Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Houston Methodist Neurological Institute</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <study_first_submitted>August 13, 2014</study_first_submitted>
  <study_first_submitted_qc>August 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2014</study_first_posted>
  <results_first_submitted>April 27, 2017</results_first_submitted>
  <results_first_submitted_qc>June 22, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">July 24, 2017</results_first_posted>
  <last_update_submitted>June 22, 2017</last_update_submitted>
  <last_update_submitted_qc>June 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mild Traumatic Brain Injury</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Volunteer Control participants were scanned only for the purpose of operator training and calibrating the MRI device. No data was collected from these participants for the the purpose of analysis.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Experimental: Diagnostic mTBI</title>
          <description>MRI Diagnostic of subjects with mild Tramatic Brain Injury (mTBI)&#xD;
MRI Diagnostic: Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences</description>
        </group>
        <group group_id="P2">
          <title>Experimental: Diagnostic Non mTBI</title>
          <description>MRI Diagnostic of Non injured subjects that are closely matched to mTBI&#xD;
MRI Diagnostic: Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences</description>
        </group>
        <group group_id="P3">
          <title>Volunteers</title>
          <description>MRI Diagnostic of Volunteer Controls for Device Calibration&#xD;
MRI Diagnostic: Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Study terminated before completed</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Experimental: Diagnostic mTBI</title>
          <description>MRI Diagnostic of subjects with mild Tramatic Brain Injury (mTBI)&#xD;
MRI Diagnostic: Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences</description>
        </group>
        <group group_id="B2">
          <title>Experimental: Diagnostic Non mTBI</title>
          <description>MRI Diagnostic of Non injured subjects that are closely matched to mTBI&#xD;
MRI Diagnostic: Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="14"/>
            <count group_id="B2" value="2"/>
            <count group_id="B3" value="16"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>mTBI Progression Indicated by Clinical Neurological Characteristics, MRI Images, and Quantitative MRI Data From Novel Software</title>
        <description>To determine associations between clinical neurological data, MR images, quantitative data from novel software post-processing (sponsor developed software including Volumetry, Kurtosis, Resting State [RS], functional magnetic resonance imaging [fMRI], and additional post-processing modules may be provided</description>
        <time_frame>Baseline to 3 months</time_frame>
        <population>Study was terminated and no subject outcome data were collected</population>
        <group_list>
          <group group_id="O1">
            <title>Experimental: Diagnostic mTBI</title>
            <description>MRI Diagnostic of subjects with mild Tramatic Brain Injury (mTBI)&#xD;
MRI Diagnostic: Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences</description>
          </group>
          <group group_id="O2">
            <title>Experimental: Diagnostic Non mTBI</title>
            <description>MRI Diagnostic of Non injured subjects that are closely matched to mTBI&#xD;
MRI Diagnostic: Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences</description>
          </group>
          <group group_id="O3">
            <title>Volunteers</title>
            <description>MRI Diagnostic of Volunteer Controls for Device Calibration&#xD;
MRI Diagnostic: Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences</description>
          </group>
        </group_list>
        <measure>
          <title>mTBI Progression Indicated by Clinical Neurological Characteristics, MRI Images, and Quantitative MRI Data From Novel Software</title>
          <description>To determine associations between clinical neurological data, MR images, quantitative data from novel software post-processing (sponsor developed software including Volumetry, Kurtosis, Resting State [RS], functional magnetic resonance imaging [fMRI], and additional post-processing modules may be provided</description>
          <population>Study was terminated and no subject outcome data were collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data was collected during the period of participant enrollment.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Experimental: Diagnostic mTBI</title>
          <description>MRI Diagnostic of subjects with mild Tramatic Brain Injury (mTBI)&#xD;
MRI Diagnostic: Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences</description>
        </group>
        <group group_id="E2">
          <title>Experimental: Diagnostic Non mTBI</title>
          <description>MRI Diagnostic of Non injured subjects that are closely matched to mTBI&#xD;
MRI Diagnostic: Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences</description>
        </group>
        <group group_id="E3">
          <title>Volunteer Controls</title>
          <description>Non injured volunteers for device calibration&#xD;
Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Headache/Dizziness</sub_title>
                <description>Subject experienced headache/dizziness after MRI</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Influenza</sub_title>
                <description>Subject diagnosed with influenza during the study</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Early termination due to limited enrollment</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Chief Medical Officer - Head Health Initiative</name_or_title>
      <organization>GE Healthcare</organization>
      <phone>262-544-3633</phone>
      <email>Victor.Miranda@ge.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

